Literature DB >> 14553896

IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants.

Janusz T Paweska1, Felicity J Burt, Fiona Anthony, Shirley J Smith, Antoinette A Grobbelaar, Janice E Croft, Tomas G Ksiazek, Robert Swanepoel.   

Abstract

The recent occurrence of the first confirmed outbreaks of Rift Valley fever in humans and livestock outside the African region, namely in the Kingdom of Saudi Arabia and Yemen, is of global medical and veterinary concern. Disadvantages of classical techniques for serological diagnosis of Rift Valley fever include health risk to laboratory personnel, restrictions for their use outside endemic areas and inability to distinguish between different classes of immunoglobulins. We report on the development and validation of sandwich and capture ELISAs (both based on inactivated antigen) for detection of IgG and IgM antibody to Rift Valley fever virus in bovine, caprine and ovine sera. Compared to virus neutralisation and haemagglutination-inhibition tests, the IgG sandwich ELISA was more sensitive in detection of the earliest immunological responses to infection or vaccination with Rift Valley fever virus. Its sensitivity and specificity derived from field data sets ranged in different ruminant species from 99.05 to 100% and from 99.1 to 99.9%, respectively. The specificity of IgM-capture ELISA varied between different species from 97.4 to 99.4%; its sensitivity was 100% in sheep tested 5-42 days post-infection. Our results in field-collected, experimental and post-vaccination sera demonstrate that these assays will be useful for epidemiological surveillance and control programmes, import/export veterinary certification, early diagnosis of infection, and for monitoring of immune response in vaccinated animals. As highly accurate and safe tests, they have the potential to replace traditional diagnostic methods, which pose biohazard risks limiting their use outside of endemic areas to high containment facilities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553896     DOI: 10.1016/s0166-0934(03)00228-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  48 in total

1.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens.

Authors:  C A Le Roux; T Kubo; A A Grobbelaar; P Jansen van Vuren; J Weyer; L H Nel; R Swanepoel; K Morita; J T Paweska
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

3.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.

Authors:  Georges Mbuyi Tshilenge; William G Dundon; Marco De Nardi; Leopold K Mulumba Mfumu; Mark Rweyemamu; Jean-Marie Kayembe-Ntumba; Justin Masumu
Journal:  Trop Anim Health Prod       Date:  2018-10-22       Impact factor: 1.559

5.  Rift Valley fever outbreak in livestock in Kenya, 2006-2007.

Authors:  Peninah Munyua; Rees M Murithi; Sherrilyn Wainwright; Jane Githinji; Allen Hightower; David Mutonga; Joseph Macharia; Peter M Ithondeka; Joseph Musaa; Robert F Breiman; Peter Bloland; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

6.  Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.

Authors:  I K Ragan; A S Davis; D S McVey; J A Richt; R R Rowland; W C Wilson
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

7.  Seroepidemiological study of Rift Valley fever (RVF) in animals in Saudi Arabia.

Authors:  Adel I Al-Afaleq; Mansour F Hussein; Abdulmohsin A Al-Naeem; Fadil Housawi; Anwar G Kabati
Journal:  Trop Anim Health Prod       Date:  2012-02-23       Impact factor: 1.559

8.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

9.  Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs.

Authors:  Olga Lihoradova; Tetsuro Ikegami
Journal:  Future Virol       Date:  2014-01-01       Impact factor: 1.831

10.  Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa.

Authors:  Marietjie Venter; Stacey Human; Dewald Zaayman; Gertruida H Gerdes; June Williams; Johan Steyl; Patricia A Leman; Janusz Tadeusz Paweska; Hildegard Setzkorn; Gavin Rous; Sue Murray; Rissa Parker; Cynthia Donnellan; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.